An analysis of STAT3 polymorphism on outcomes of interferon-alpha treatment in patients with metastatic renal cell carcinoma.
M. Eto
No relevant relationships to disclose
T. Kamba
No relevant relationships to disclose
H. Miyake
No relevant relationships to disclose
M. Fujisawa
No relevant relationships to disclose
K. Yoshida
No relevant relationships to disclose
H. Uemura
No relevant relationships to disclose
T. Tsukamoto
No relevant relationships to disclose
Y. Katsuoka
No relevant relationships to disclose
A. Matsubara
No relevant relationships to disclose
K. Nishimura
No relevant relationships to disclose
T. Nakamura
No relevant relationships to disclose
O. Ogawa
No relevant relationships to disclose
S. Naito
No relevant relationships to disclose